Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,132 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06343714RecruitingPhase 1
Testing a new drug for knee osteoarthritis pain
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
Brisbane, QueenslandAges 18–75 - NCT06911489RecruitingPhase 1
Safety trial of a new targeted therapy for advanced solid tumors
This trial tests a new drug, NRT6020, that targets a protein called FAP found on many solid tumors. It aims to see if the drug is safe and how it works in people with advanced solid tumors that have not responded to other treatments.
ShanghaiAges 18–80 - NCT06905808Recruiting
Normal Bladder Pressure Values Using e-Sense Catheter
This study uses a special catheter to measure normal bladder pressures during a standard bladder test. It aims to find what normal pressure values are for different ages and genders.
BristolAges 20 years+ - NCT06306326Recruiting
Using 3D scanning to check fat grafting for facial defects
This study uses 3D face scanning to see how well your own fat, taken from another part of your body, can restore fullness to your face. It might help if you have a sunken or uneven look from a birth defect, injury, or aging.
Beijing, Beijing MunicipalityAges 3–80 - NCT05888428Recruiting
Test of a smart arm prosthesis control system for arm amputees
This trial studies whether the MyoTrain system can help people with a below-elbow (trans-radial) arm amputation control a myoelectric prosthesis using muscle signals. It may help you practice and use a more “thought-to-movement” style control method if you meet the safety and participation requirements.
Grand Rapids, MichiganAges 18 years+ - NCT06803602Enrolling by invitation
Magnetic therapy for urine leaks after prostate surgery
This trial tests a non-invasive magnetic treatment (HIFEM) to help men with urine leaks after prostate cancer removal (radical prostatectomy) or HoLEP surgery. The goal is to see if it improves bladder control and quality of life.
Scottsdale, ArizonaAges 18–100 - NCT06770972Recruiting
Parenting support for IVF and ART families
This study tests a virtual class for people who became pregnant through fertility treatments like IVF. The class aims to help you and your caregiving partner build a strong foundation for your family.
Los Angeles, CaliforniaAges 18 years+ - NCT05907421Recruiting
Study of emotional control in teens who self-harm
This study looks at how emotion control works in teens who have self-harmed (NSSI) in everyday situations, using brain and behavior measurements. You might help researchers understand what triggers and maintains self-harm, which could guide future supports.
Chengdu, SichuanAges 15–18 - NCT06717880RecruitingPhase 1
Combination therapy for advanced colorectal cancer
This trial tests a new drug (IBI363) combined with either bevacizumab or furuitinib for people with advanced colorectal cancer that has worsened after standard treatments. It aims to find a more effective option for those who have limited alternatives.
Wuhan, HubeiAges 18–75 - NCT06710678Recruiting
Study breaks and thinking skills in medical students
This trial looks at how different types of study breaks affect attention and thinking in medical students. You will try brief social media or physical activity breaks to see which helps you think best.
Old Westbury, New YorkAges 18 years+ - NCT07347080RecruitingEarly Phase 1
Study of a new RNA-based drug for type 2 diabetes
This trial tests an experimental injection (CR059) for type 2 diabetes. It looks at safety and how the body handles different doses. You may qualify if you have had diabetes for 3 months to 5 years and are currently managing it with diet/exercise or certain diabetes pills.
Luoyang, HenanAges 18–65 - NCT07348653RecruitingPhase 1
Study of MG2512 for advanced solid tumor patients
This trial tests a new drug called MG2512 for people with advanced solid tumors that have not responded to standard treatments or who cannot take standard therapy. The study aims to understand if MG2512 is safe and effective.
Beijing, Beijing MunicipalityAges 18–75 - NCT07260578Enrolling by invitation
Ellacor skin treatment for moderate to severe face wrinkles
This trial tests a device called Ellacor that uses tiny needles to remove small cores of skin, which helps reduce wrinkles on the mid and lower face. The study follows best practices for the procedure and aftercare to see how well it works and if it's safe.
Miami, FloridaAges 45–65 - NCT06659913Recruiting
Increasing physical activity for body and mind
This study is testing whether increasing physical activity can improve both your body and mind. It's for people who are currently not very active and want to see if moving more makes a difference.
TrondheimAges 12–17 - NCT06658353RecruitingPhase 3
Study of VC004 for advanced solid tumors
This trial tests a new drug called VC004 for people with advanced solid tumors that have spread. It aims to see if the drug can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 12 years+ - NCT06636838Recruiting
Language and fertility treatment
This study looks at how language affects the experience of people getting fertility treatment. If Spanish is your preferred language, the researchers want to learn if speaking Spanish with your doctor helps you feel more comfortable and supported.
St Louis, MissouriAges 18 years+ - NCT07368803RecruitingPhase 1/Phase 2
Personalized mRNA vaccine for bile duct cancer after surgery
This trial tests a personalized mRNA vaccine (iNeo-Vac-R01) made from your tumor's unique markers to help prevent cancer from coming back after surgery for bile duct or other digestive cancers. It may be an option if standard treatments have stopped working or caused side effects.
Hangzhou, ZhejiangAges 18–75 - NCT05968313Recruiting
Brain scan study of pain feelings in teens who self-harm
This study uses brain activity during a task to understand how teens who self-harm react to pain and empathy. It may help researchers learn what brain differences are linked with non-suicidal self-injury and guide better support for teens.
Chengdu, SichuanAges 15–18 - NCT07734207Recruiting
Nocturia app and behavior help trial
This trial tests if a smartphone app (LINE) and simple behavior changes can reduce how often you wake up to urinate at night. You may qualify if you get up to pee at least twice each night.
DouliuAges 55 years+ - NCT06587360Recruiting
FertiShare study: sharing fertility information
This study looks at a new way for fertility clinics to share information with patients. It aims to see if this helps patients and clinics work better together.
Aberdeen, AberdeenAges 18 years+ - NCT07732803Recruiting
Robotic surgery results for bone injuries
This study looks at how well robots can help in surgery for broken bones and other orthopedic injuries. If you are an adult with a fracture and need surgery, you may be able to join.
Hong KongAges 18 years+ - NCT07278882Recruiting
Mobile app support for home maintenance therapy in childhood leukemia
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
Tianjin, Tianjin MunicipalityAges Up to 16 years - NCT07053618Recruiting
Heart pump support for high-risk heart procedures
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Beijing, Beijing MunicipalityAges 18–90 - NCT06512428RecruitingPhase 2
Simmitinib plus irinotecan for advanced esophageal cancer
This trial tests a new combination of two drugs—simmitinib (a targeted therapy) and irinotecan (a chemotherapy)—for people with advanced esophageal cancer that has stopped responding to one prior treatment. The goal is to see if this combination can shrink tumors or slow the cancer's growth.
Heilongjiang, HarbinAges 18–70
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,132 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.